ArticleSleep2026
Performance of an electroencephalography-measuring headband or actigraphy compared with polysomnography in older adults with sleep disturbances.
Article in Sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of Wearable Digital Therapeutics in Improving Sleep Outcomes Among Individuals With Insomnia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2026Pooled it
Corrections and comments
- Update of
Authors and funding
14 authors.
Funding
Abstract
STUDY
objectivesWe assessed the performance of an electroencephalography-measuring headband (HB) or actigraphy (ACT) compared with polysomnography (PSG) in older adults with sleep disturbances.
methodsSixty-one older adults reporting insomnia and/or daytime sleepiness wore the HB for up to 7 nights, ACT for 7 days and nights, and completed an in-home PSG. We compared total sleep time (TST), wake after sleep onset (WASO), sleep onset latency (SOL), and sleep efficiency (SE) from all devices on the PSG night. For HB-PSG, we compared time in light, deep, and rapid eye movement sleep. For all comparisons, we calculated absolute differences and intraclass correlation coefficients (ICCs). We also evaluated the performance of the HB among the poorest sleepers (e.g. severe sleep apnea or insomnia).
resultsAverage age was 72.6 [SD = 6.5] years, 62.3 per cent were female, and 77.1 per cent were non-Hispanic white. For HB-PSG, we found good agreement for TST, WASO, and SE (ICCs ranging 0.82-0.91), while SOL and sleep stages were lower (ICCs 0.44-0.66). For ACT-PSG, we found moderate agreement for TST (ICC 0.73) and poor agreement for WASO, SOL, and SE (ICCs < 0.50). For the poorest sleepers, HB-PSG showed good to excellent agreement for TST and WASO (ICCs 0.56-0.91), while ACT-PSG showed lower levels of agreement (ICCs 0.55-0.80 for TST and <0.59 for WASO). On average, participants wore the HB for 6.5 [0.8] nights and usability was rated highly.
conclusionsThe HB outperformed ACT, including among the poorest sleepers. Devices like the HB are accurate, feasible, and could advance sleep health in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.